NCT07203742Recruiting
The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
This study aims to examine the effect of mandala coloring activity, administered before intrathecal chemotherapy treatment in children with leukemia, on pre-procedure anxiety and fear in children. The main question this study aims to answer is: Does mandala coloring administered before intrathecal chemotherapy treatment reduce pre-procedure anxiety and fear in children with leukemia? Descriptive demographic data will be collected from the children who will be given mandalas. Data will be collected using an Anxiety Scale and a Fear Scale.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 23 Sept 2025
- Start date
- 29 Sept 2025
- Primary completion date
- Aug 2026
- Lead sponsor
- Ege University
- NCT number
- NCT07203742
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 29 Sept 2025 to the primary completion date, Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Cases that do not meet the inclusion criteria will be excluded from the study.
Who the study is looking for
- The patient must be between 4 and 12 years of age.
- The patient must be hospitalized and followed up at the Pediatric Hematology Clinic.
- The patient must only be receiving leukemia treatment.
- The patient must not have any other chronic diseases.
- The patient must not have any systemic infections.
- The patient has received at least two courses of intrathecal chemotherapy treatment
- The patient does not have a diagnosis of psychological/mental symptoms as a side effect of chemotherapy treatment
- Intrathecal treatment will be administered to the patient in accordance with the chemotherapy protocol
- The patient and the caregiver parent are volunteers
- The caregiver parent speaks Turkish and is open to communication.
Age in the registry: 4 years to 12 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ege University Childrens Hospital Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.